Co-treatment with melatonin and ortho-topolin riboside reduces cell viability by altering metabolic profiles in non-small cell lung cancer cells
Chem Biol Interact. 2024 Feb 5:110900. doi: 10.1016/j.cbi.2024.110900. Online ahead of print.NO ABSTRACTPMID:38325522 | DOI:10.1016/j.cbi.2024.110900
Source: Chemico-Biological Interactions - Category: Molecular Biology Authors: Ji Won Lee Hwanhui Lee Soon-Wook Noh Hyung-Kyoon Choi Source Type: research
More News: Cancer | Cancer & Oncology | Chemistry | Lung Cancer | Melatonin | Molecular Biology | Non-Small Cell Lung Cancer